What You Should Know: - C2i Genomics, a cancer intelligence company launches its C2inform minimal residual disease (MRD) test across Europe, after obtaining CE-IVD marking in the EU, UK and Switzerland. The company also announced the completion of several clinical trials across the globe, including leading cancer centers in Europe, U.S. and Singapore. - The new clinical data will be presented at the 2022 American Association for Cancer Research (AACR) annual meeting in New Orleans,
Read More
Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant
Cardiologs’ AI Dramatically Reduces Inconclusive Apple Watch ECGs
What You Should Know: - Cardiologs, a provider of artificial intelligence (AI) cardiology diagnostics, today announced the results of a new clinical study that showed Cardiologs’ deep learning AI dramatically reduces inconclusive results returned by the latest Apple Watch ECG companion app (Apple ECG 2.0) while maintaining performance (sensitivity and specificity). - The study included 101 patients in a typical tertiary care hospital who were assessed for atrial arrhythmia (AA). It
Read More
Dental AI Startup VideaHealth Nabs $20M to Expand AI-Based Diagnostics
What You Should Know: - VideaHealth, a dental diagnostic AI solution raises $20M in Series A funding led by Spark Capital including existing investors Zetta Venture Partners. Pillar VC also contributed to the round, bringing the company to $26.4M to date. - The company will use the financing to expand its groundbreaking AI-based diagnostics capabilities to over 6000 dental practices by the end of 2023. Transforming Dentistry Through AI Today, more than 40% of dental
Read More
Researchers Develop AI Method for Personalized Diabetes Treatment
What You Should Know: - Hitachi, U of U Health, and Regenstrief researchers partnered to develop and test a new AI method to improve personalized care for diabetes patients needing complex drug treatment. - The new AI method can now be used to help determine an optimal drug regimen for a specific patient. Hitachi, University of Utah Health, and Regenstrief Institute today announced the development of an artificial intelligence (AI) method to improve care for patients with type 2
Read More
Why Mainstream Precision Medicine Hinges on Healthcare HPC Storage
The healthcare industry is experiencing a data deluge, and it shows no sign of slowing down. In 2020, estimates reported that healthcare data comprised a staggering 30% of the world’s total data volume; projections for 2025 bump that number up to 36%, a growth rate outpacing every other industry. This is promising news for precision medicine, the data-driven healthcare initiative that promotes the right treatment for the right patient at the right time. Precision (or personalized)
Read More
When Automation Meets Empathy: Intelligent Virtual Assistants for Healthcare
Advances in conversational artificial intelligence are transforming basic chatbots into intelligent virtual assistants that provide comfort and utility for healthcare consumers and the healthcare organizations that serve them. Most consumers have their minds made up about automated phone agents, and not too many people like them. Who among us hasn’t experienced the frustration of an automated phone menu when calling for a doctor's appointment or shouted “representative!” into our
Read More
CMR Surgical Launches VR Education Solution for Soft Tissue Robotic Surgery
What You Should Know: - Today, CMR Surgical has announced a VR professional education program for its Versius® Surgical Robotic System. - The announcement marks CRM Surgical as the first soft-tissue surgical robotics system to offer VR training as part of its surgical team training pathway; giving surgical teams increased flexibility to practice their skills. VR Training for Surgical Robot The VR headset solution was
Read More
Tempus Launches Pathology-Driven AI Platform
What You Should Know: - Tempus, a provider of artificial intelligence and precision medicine, today announced the launch of Edge, an innovative platform that allows pathologists to access developing AI models intended to identify specimens with potentially actionable biomarkers using a single hematoxylin and eosin stain (H&E) slide. - With access to over 50 petabytes of de-identified multimodal data, Tempus is developing AI models with the aim to identify patients who would
Read More
Canopy Launches Out of Stealth with $13M for Intelligent Care Platform for Oncology
What You Should Know: - Today, Canopy announced it is launching out of stealth with $13 million in funding to work with leading oncology practices all over the country to help deliver high-quality care to cancer patients when they aren’t in the doctor’s office. - Canopy works with leading oncology practices nationwide to drive the best possible outcomes for over 50,000 cancer patients. Canopy, a Palo Alto, CA-based Intelligent Care Platform (ICP) for oncology, today
Read More
Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration
Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More
